pemigatinib,infigratinib
bridgebio pharmaceutical,incyte
['biomarker', 'pemigatinib', 'infigratinib']
read this cancer discovery news in brief story on how infigratinib compares to pemigatinib for background information prior to the talk on the fight-207 trial of pemigatinib at the #aacr23 session biomarker-driven molecularly targeted therapy 
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.